Drug treatment of vestibular migraine
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/17414 |
Resumo: | Vestibular migraine corresponds to one of the most frequent diagnoses in otoneurology. It is considered the most common cause of balance disorders. Its diagnosis is based on recurrent vestibular symptoms, history of migraine and association of migraine symptoms with vestibular symptoms over a period ranging from 5 minutes to 72 hours. The drug treatment of vestibular migraine aims to control the patient's symptoms in the acute phase, as well as in the prophylaxis of eventual crises. The present work is an integrative literature review, whose objective is to identify and describe the drug treatment of vestibular migraine, in order to control the patient's symptoms in the acute phase and in the prophylaxis of possible crises. The search was carried out in the electronic databases SCIELO, PUBMED and LILACS, including works published between 2016 and 2021, in Portuguese and English. The selection of studies, data extraction and validation were carried out independently by two authors, obtaining a sample of 14 articles. All research data were analyzed in Microsoft Excel and later the results were transformed into tables for a better interpretation of the information collected. It was found, through the analysis of the 14 articles, that 7 (50%) studies used treatment with antidepressants, beta-blockers and anticonvulsants concomitantly; 9 (64%) used propranolol with symptom improvement; 2 (14%) used botulinum toxin and only 1 (7%) used gentamicin injection. Thus, it was possible to systematically structure the drugs most used in prophylaxis and in the vestibular migraine crisis, laying the basis for a more adequate choice of the drug. |
id |
UNIFEI_11054e886d7ca60ecbde5ac2219d08de |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/17414 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Drug treatment of vestibular migraineTratamiento medicamentoso de la migraña vestibularTratamento medicamentoso da migrânea vestibularMigraine disordersVestibular diseasesDrug therapy.Trastornos de migrañaEnfermedades vestibularesTratamiento farmacológico.Transtornos de enxaquecaDoenças vestibularesTratamento farmacológico. Vestibular migraine corresponds to one of the most frequent diagnoses in otoneurology. It is considered the most common cause of balance disorders. Its diagnosis is based on recurrent vestibular symptoms, history of migraine and association of migraine symptoms with vestibular symptoms over a period ranging from 5 minutes to 72 hours. The drug treatment of vestibular migraine aims to control the patient's symptoms in the acute phase, as well as in the prophylaxis of eventual crises. The present work is an integrative literature review, whose objective is to identify and describe the drug treatment of vestibular migraine, in order to control the patient's symptoms in the acute phase and in the prophylaxis of possible crises. The search was carried out in the electronic databases SCIELO, PUBMED and LILACS, including works published between 2016 and 2021, in Portuguese and English. The selection of studies, data extraction and validation were carried out independently by two authors, obtaining a sample of 14 articles. All research data were analyzed in Microsoft Excel and later the results were transformed into tables for a better interpretation of the information collected. It was found, through the analysis of the 14 articles, that 7 (50%) studies used treatment with antidepressants, beta-blockers and anticonvulsants concomitantly; 9 (64%) used propranolol with symptom improvement; 2 (14%) used botulinum toxin and only 1 (7%) used gentamicin injection. Thus, it was possible to systematically structure the drugs most used in prophylaxis and in the vestibular migraine crisis, laying the basis for a more adequate choice of the drug.La migraña vestibular corresponde a uno de los diagnósticos más frecuentes en otoneurología. Se considera la causa más común de trastornos del equilibrio. Su diagnóstico se basa en síntomas vestibulares recurrentes, antecedentes de migraña y la asociación de síntomas de migraña con síntomas vestibulares durante un período que va de 5 minutos a 72 horas. El tratamiento farmacológico de la migraña vestibular tiene como objetivo controlar los síntomas del paciente en la fase aguda, así como en la profilaxis de eventuales crisis. El presente trabajo es una revisión integradora de la literatura, cuyo objetivo es identificar y describir el tratamiento farmacológico de la migraña vestibular, con el fin de controlar los síntomas del paciente en la fase aguda y en la profilaxis de posibles crisis. La búsqueda se realizó en las bases de datos electrónicas SCIELO, PUBMED y LILACS, incluyendo trabajos publicados entre 2016 y 2021, en portugués e inglés. La selección de estudios, extracción de datos y validación fueron realizadas de forma independiente por dos autores, obteniendo una muestra de 14 artículos. Todos los datos de la investigación fueron analizados en Microsoft Excel y posteriormente los resultados se transformaron en tablas para una mejor interpretación de la información recolectada. Se encontró, mediante el análisis de los 14 artículos, que 7 (50%) estudios utilizaron tratamiento con antidepresivos, betabloqueantes y anticonvulsivos de forma concomitante; 9 (64%) usaron propranolol con mejoría de los síntomas; 2 (14%) usó toxina botulínica y solo 1 (7%) usó la inyección de gentamicina. Así, fue posible estructurar sistemáticamente los fármacos más utilizados en profilaxis y en la crisis migrañosa vestibular, sentando las bases para una elección más adecuada del fármaco.Migrânea vestibular corresponde a um dos mais frequentes diagnósticos em otoneurologia. É considerada a causa mais comum de distúrbios de equilíbrio. Seu diagnóstico é baseado em sintomas vestibulares recorrentes, história de migrânea e a associação dos sintomas migranosos com os sintomas vestibulares em um período que varia de 5 minutos a 72 horas. O tratamento medicamentoso da migrânea vestibular objetiva o controle dos sintomas do paciente na fase aguda, bem como na profilaxia das eventuais crises. O presente trabalho é uma revisão integrativa da literatura, cujo objetivo é identificar e descrever o tratamento medicamentoso da migrânea vestibular, a fim de controlar os sintomas do paciente na fase aguda e na profilaxia das eventuais crises. A busca foi realizada nas bases de dados eletrônicas SCIELO, PUBMED e LILACS, incluindo trabalhos publicados entre 2016 e 2021, em língua portuguesa e inglesa. A seleção dos estudos, extração de dados e validação foram realizadas de forma independente por dois autores, obtendo amostra de 14 artigos. Todos os dados da pesquisa foram analisados no Microsoft Excel e posteriormente os resultados foram transformados em tabelas para melhor interpretação das informações coletadas. Constatou-se, através da análise dos 14 artigos, que 7 (50%) estudos utilizaram tratamento com antidepressivos, betabloqueadores e anticonvulsivantes concomitantemente; 9 (64%) utilizaram propranolol com melhora dos sintomas; 2 (14%) utilizaram a toxina botulínica e em apenas 1 (7%) foi utilizado a injeção com gentamicina. Assim, foi possível estruturar de forma sistemática os medicamentos mais utilizados na profilaxia e na crise da migrânea vestibular, lançando base para escolha mais adequada do fármaco.Research, Society and Development2021-07-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1741410.33448/rsd-v10i8.17414Research, Society and Development; Vol. 10 No. 8; e32110817414Research, Society and Development; Vol. 10 Núm. 8; e32110817414Research, Society and Development; v. 10 n. 8; e321108174142525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/17414/15536Copyright (c) 2021 Siméia de Castro Ramos; Sueli de Souza Costa; Patrick Rademaker Burkehttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRamos, Siméia de CastroCosta, Sueli de SouzaBurke, Patrick Rademaker2021-08-21T18:46:59Zoai:ojs.pkp.sfu.ca:article/17414Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:37:45.423503Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Drug treatment of vestibular migraine Tratamiento medicamentoso de la migraña vestibular Tratamento medicamentoso da migrânea vestibular |
title |
Drug treatment of vestibular migraine |
spellingShingle |
Drug treatment of vestibular migraine Ramos, Siméia de Castro Migraine disorders Vestibular diseases Drug therapy. Trastornos de migraña Enfermedades vestibulares Tratamiento farmacológico. Transtornos de enxaqueca Doenças vestibulares Tratamento farmacológico. |
title_short |
Drug treatment of vestibular migraine |
title_full |
Drug treatment of vestibular migraine |
title_fullStr |
Drug treatment of vestibular migraine |
title_full_unstemmed |
Drug treatment of vestibular migraine |
title_sort |
Drug treatment of vestibular migraine |
author |
Ramos, Siméia de Castro |
author_facet |
Ramos, Siméia de Castro Costa, Sueli de Souza Burke, Patrick Rademaker |
author_role |
author |
author2 |
Costa, Sueli de Souza Burke, Patrick Rademaker |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Ramos, Siméia de Castro Costa, Sueli de Souza Burke, Patrick Rademaker |
dc.subject.por.fl_str_mv |
Migraine disorders Vestibular diseases Drug therapy. Trastornos de migraña Enfermedades vestibulares Tratamiento farmacológico. Transtornos de enxaqueca Doenças vestibulares Tratamento farmacológico. |
topic |
Migraine disorders Vestibular diseases Drug therapy. Trastornos de migraña Enfermedades vestibulares Tratamiento farmacológico. Transtornos de enxaqueca Doenças vestibulares Tratamento farmacológico. |
description |
Vestibular migraine corresponds to one of the most frequent diagnoses in otoneurology. It is considered the most common cause of balance disorders. Its diagnosis is based on recurrent vestibular symptoms, history of migraine and association of migraine symptoms with vestibular symptoms over a period ranging from 5 minutes to 72 hours. The drug treatment of vestibular migraine aims to control the patient's symptoms in the acute phase, as well as in the prophylaxis of eventual crises. The present work is an integrative literature review, whose objective is to identify and describe the drug treatment of vestibular migraine, in order to control the patient's symptoms in the acute phase and in the prophylaxis of possible crises. The search was carried out in the electronic databases SCIELO, PUBMED and LILACS, including works published between 2016 and 2021, in Portuguese and English. The selection of studies, data extraction and validation were carried out independently by two authors, obtaining a sample of 14 articles. All research data were analyzed in Microsoft Excel and later the results were transformed into tables for a better interpretation of the information collected. It was found, through the analysis of the 14 articles, that 7 (50%) studies used treatment with antidepressants, beta-blockers and anticonvulsants concomitantly; 9 (64%) used propranolol with symptom improvement; 2 (14%) used botulinum toxin and only 1 (7%) used gentamicin injection. Thus, it was possible to systematically structure the drugs most used in prophylaxis and in the vestibular migraine crisis, laying the basis for a more adequate choice of the drug. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-07-13 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/17414 10.33448/rsd-v10i8.17414 |
url |
https://rsdjournal.org/index.php/rsd/article/view/17414 |
identifier_str_mv |
10.33448/rsd-v10i8.17414 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/17414/15536 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Siméia de Castro Ramos; Sueli de Souza Costa; Patrick Rademaker Burke https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Siméia de Castro Ramos; Sueli de Souza Costa; Patrick Rademaker Burke https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 8; e32110817414 Research, Society and Development; Vol. 10 Núm. 8; e32110817414 Research, Society and Development; v. 10 n. 8; e32110817414 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052682393878528 |